:internalReference - mesalazine | 89-57-6

Mesalazine

Mesalazine is an anti-inflammatory drug, which is a derivative of 5-aminosalicylic acid (5-ASA). It is sourced synthetically through aminosalicylic compound modification. The mode of action of mesalazine involves its ability to act topically on the colonic epithelium to inhibit leukotriene synthesis and block cyclooxygenase pathways. This suppresses the production of pro-inflammatory cytokines and reactive oxygen species in the gut mucosa.Mesalazine is primarily used in the treatment of inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. It helps in reducing inflammation, thus controlling symptoms like diarrhea, rectal bleeding, and abdominal pain. The ability of mesalazine to target specific sites within the intestines and its efficacy in maintaining remission makes it a vital therapeutic agent in gastroenterology.

MESALAZINE CRS

MESALAZINE FOR SYSTEM SUITABILITY CRS